Forte Biosciences, Inc. announced earnings results for the first quarter ended March 31, 2021. For the quarter, the company reported loss from operations was $4,741,000 against $2,027,000 a year ago. Net loss was $4,804,000 against $2,050,000 a year ago. Net loss per share - basic and diluted was $0.36 against $0.97 a year ago.